Corporate Banner
Satellite Banner
Technology Networks Header
Monday, July 28, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Rosetta Genomics, Moffitt Cancer Center Enter mRNA-Based Cancer Diagnostic Agreement
Tuesday, June 10, 2014
Partnership to advance the development and commercialization of Rosetta's thyroid neoplasia assay.

JAX and Frasergen Announce Cancer Genomics Facility in Hubei Province, China
Tuesday, June 10, 2014
Researchers investigate cancers and their response to novel drugs and immunotherapies using the Laboratory’s innovative cancer tools.

Shuwen Biotech and DiagnoCure Sign Exclusive License and Collaboration Agreement
Saturday, June 07, 2014
Agreement for commercializing Previstage™ GCC colorectal cancer staging test in China.

Ventana, MedImmune to Develop a custom Assay Immunotherapy for Clinical Trials
Thursday, June 05, 2014
Companies are jointly developing a PD-L1 (SP263) immunohistochemistry assay to enroll patients in clinical trials for MedImmune's MEDI4736 anti-PD-L1 therapy for non-small cell lung carcinoma.

New Test Predicts If Breast Cancer Will Spread
Thursday, June 05, 2014
A test that counts the number of locations in tumor specimens where tumor cells may invade blood vessels predicted the risk of metastasis for the most common type of breast cancer.

Merck’s Melanoma Drug Shows Overall Survival Rate of 69%
Wednesday, June 04, 2014
Pembrolizumab as monotherapy shows estimated overall survival rate at one year across 411 advanced melanoma patients with varying stages of disease and prior therapy.

Agalimmune Receives £1.2 million ($2 million) Milestone Payment
Wednesday, June 04, 2014
Agalimmune’s Alphaject technology, an injectable oncology therapy has completed a Phase I trial in melanoma. Data presented at AACR and ASCO.

‘Liquid Biopsy’ Offers New Way to Track Lung Cancer
Wednesday, June 04, 2014
Scientists have shown how a lung cancer patient’s blood sample could be used to monitor and predict their response to treatment.

New Insight into Drug Resistance in Metastatic Melanoma
Wednesday, June 04, 2014
A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 3053
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv